Comprehensive transcriptomic analysis of immune-related genes in diabetic foot ulcers: New insights into mechanisms and therapeutic targets
RNA-seq (gene expression) · human · 21 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 21 samples: 21 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Comprehensive transcriptomic analysis of immune-related genes in diabetic foot ulcers: New insights into mechanisms and therapeutic targetsInternational immunopharmacology · 2024
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE199939_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA822286 and SRA study SRP367217. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 21 sample titles: 21 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM5994301 Diabetic Foot Skin Donor #1 [DW1]
- GSM5994302 Diabetic Foot Skin Donor #2 [DW2]
- GSM5994303 Diabetic Foot Skin Donor #3 [DW3]
- GSM5994304 Diabetic Foot Skin Donor #4 [DW4]
- GSM5994305 Diabetic Foot Skin Donor #5 [DW5]
- GSM5994306 Diabetic Foot Skin Donor #6 [DW6]
- GSM5994307 Diabetic Foot Skin Donor #7 [DW7]
- GSM5994308 Diabetic Foot Skin Donor #8 [DW8]
- GSM5994309 Diabetic Foot Skin Donor #9 [DW9]
- GSM5994310 Diabetic Foot Skin Donor #10 [DW10]
- GSM5994311 Non-Diabetic Foot Skin Donor #1 [N1]
- GSM5994312 Non-Diabetic Foot Skin Donor #2 [N2]
- GSM5994313 Non-Diabetic Foot Skin Donor #3 [N3]
- GSM5994314 Non-Diabetic Foot Skin Donor #4 [N4]
- GSM5994315 Non-Diabetic Foot Skin Donor #5 [N5]
- GSM5994316 Non-Diabetic Foot Skin Donor #6 [N6]
- GSM5994317 Non-Diabetic Foot Skin Donor #7 [N7]
- GSM5994318 Non-Diabetic Foot Skin Donor #8 [N8]
- GSM5994319 Non-Diabetic Foot Skin Donor #9 [N9]
- GSM5994320 Non-Diabetic Foot Skin Donor #10 [N10]
- GSM5994321 Non-Diabetic Foot Skin Donor #11 [N11]
- GSE300628 HER2 heterogeneous breast cancer models reveal novel therapeutic targets and subclonal dynamics during evolution to resistance to HER2-targeted therapies 60 samples shares therapeutic, targets
- GSE145057 Establishment of a human tongue cancer organoid biobank enables early diagnosis, prognosis, and identification of therapeutic targets 25 samples shares therapeutic, targets
- GSE244832 Multi-Modal Comparison of human Hepatic Stellate Cells identifies novel therapeutic targets for Metabolic Dysfunction-Associated Steatotic Liver Disease 36 samples shares therapeutic, targets
- GSE264741 Functional Screening and Transcriptomic Analysis Identify Novel Druggable Dependencies and Immunotherapy Targets in Desmoplastic Small Round Cell Tumor 124 samples shares targets
- GSE309595 Longitudinal Analysis of Multiple Myeloma: Therapeutic Response and Immune Microenvironment Dynamics in the Context of Tumor Heterogeneity [scRNA-seq] 270 samples shares therapeutic
- GSE312236 Comprehensive proteogenomic analysis identifies immune targets in microsatellite stable and unstable colorectal cancers 26 samples shares targets
- GSE215274 Identification of Whole Blood Gene Expression Signature to Predict the Therapeutic Effect of Nintedanib in Idiopathic Pulmonary Fibrosis 177 samples shares therapeutic
- GSE210098 Glomerular transcriptomics predicts outcome and identifies therapeutic strategies for patients with assumed benign IgA nephropathy 17 samples shares therapeutic
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.